The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder.

Felmingham KL, Dobson-Stone C, Schofield PR, Quirk GJ, Bryant RA. The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder. Biol Psychiatry. 2013 Jun 01; 73(11):1059-63.

View in: PubMed

subject areas

Adult
Analysis of Variance
Brain-Derived Neurotrophic Factor
Female
Genotype
Humans
Implosive Therapy
Male
Methionine
Middle Aged
Polymorphism, Genetic
Predictive Value of Tests
Regression Analysis
Stress Disorders, Post-Traumatic
Trauma Severity Indices
Treatment Outcome
Valine

authors with profiles

Gregory J. Quirk

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support